135 related articles for article (PubMed ID: 3339603)
1. Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.
Fossheim R; Joslyn A; Solo AJ; Luchowski E; Rutledge A; Triggle DJ
J Med Chem; 1988 Feb; 31(2):300-5. PubMed ID: 3339603
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
Fossheim R; Svarteng K; Mostad A; Rømming C; Shefter E; Triggle DJ
J Med Chem; 1982 Feb; 25(2):126-31. PubMed ID: 7057416
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activators related to Bay K 8644 in smooth muscle, cardiac muscle and neuronal preparations.
Kwon YW; Franckowiak G; Langs DA; Hawthorn M; Joslyn A; Triggle DJ
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):19-30. PubMed ID: 2471085
[TBL] [Abstract][Full Text] [Related]
5. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the dihydropyridine Ca2+ antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data.
Fossheim R
J Med Chem; 1986 Feb; 29(2):305-7. PubMed ID: 3005572
[TBL] [Abstract][Full Text] [Related]
8. The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissues.
Kwon YW; Zhong Q; Wei XY; Zheng W; Triggle DJ
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):128-36. PubMed ID: 2156174
[TBL] [Abstract][Full Text] [Related]
9. Interactions of analogs of the 1,4-dihydropyridine tiamdipine in cardiac and smooth muscle.
Galletti F; Zheng W; Gopalakrishnan M; Rutledge A; Triggle DJ
Eur J Pharmacol; 1991 Mar; 195(1):125-9. PubMed ID: 2065707
[TBL] [Abstract][Full Text] [Related]
10. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
Campbell KP; Sharp A; Strom M; Kahl SD
Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
[TBL] [Abstract][Full Text] [Related]
14. Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers.
Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A
J Med Chem; 1988 May; 31(5):936-44. PubMed ID: 2834556
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Evaluation of Pharmacological Activity, and Molecular Docking of 1,4-Dihydropyridines as Calcium Antagonists.
Shaldam MA; El-Hamamsy MH; Saleh DO; El-Moselhy TF
Chem Pharm Bull (Tokyo); 2016; 64(4):297-304. PubMed ID: 26822207
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthioimidazole substituent.
Foroumadi A; Analuie N; Rezvanipour M; Sepehri G; Najafipour H; Sepehri H; Javanmardi K; Esmaeeli F
Farmaco; 2002 Mar; 57(3):195-9. PubMed ID: 11989797
[TBL] [Abstract][Full Text] [Related]
18. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent.
Thomas G; Chung M; Cohen CJ
Circ Res; 1985 Jan; 56(1):87-96. PubMed ID: 2578336
[TBL] [Abstract][Full Text] [Related]
19. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
20. Cardioactivity and solid-state structure of two 4-isoxazolyldihydropyridines related to the 4-aryldihydropyridine calcium-channel blockers.
McKenna JI; Schlicksupp L; Natale NR; Willett RD; Maryanoff BE; Flaim SF
J Med Chem; 1988 Feb; 31(2):473-6. PubMed ID: 3339618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
